Alaska Senate Bill SB133

Alaska 2023-2024 Regular Session

• Introduced: 4/21/23
• Refer: 4/21/23

Caption

Opioid Remediation Funds

Impact

The Alaska opioid settlement investment fund is set up to maintain a reliable source of funding by accumulating resources derived from appropriations, investments, and donations. The legislature has discretion over the amount appropriated to this fund, allowing for flexibility in addressing the state's needs as they relate to opioid-related issues. The fund does not lapse, signifying a long-term commitment to handling the fallout from the opioid epidemic. This will enable sustained funding for initiatives that prioritize recovery and prevention over time.

Summary

Senate Bill 133, introduced in the Alaska Legislature, establishes two key funds aimed at addressing the opioid crisis: the Alaska opioid settlement investment fund and the Alaska opioid remediation fund. The purpose of these funds is to provide financial support for the prevention of opioid addiction, harm reduction strategies, and related treatment and educational programs. The legislation mandates that money appropriated to these funds must comply with settlement agreements between the state and opioid manufacturers and distributors, ensuring that funds are utilized strictly for opioid-related issues.

Contention

Notably, opposition may arise surrounding the management and distribution of these funds. Critics might question the efficiency and transparency of how the funds are allocated and utilized, particularly regarding administrative costs. Furthermore, as the bill allows for the commissioner of health to expend funds without further legislative appropriation for specific programs, there may be concerns about oversight and accountability. The bill's implications for local health initiatives and community-based recovery programs may spark debate on the adequacy of support provided to local jurisdictions in managing the opioid crisis effectively.